Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients

• Status: Completed
• Trial end date: 2020-10-14
• Target enrollment: 0
• Participant gender: All

Summary

A randomized controlled trial on using Ivermectin and doxycycline to treat mild-moderate outpatients, severe, and critical inpatients of Coronavirus disease 19 (COVID-19) along with standard of care. Seventy Iraqi COVID-19 patients received Ivermectin and Doxycycline plus standard of care versus seventy Iraqi COVID-19 patients received standard of care only. .

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alkarkh Health Directorate-Baghdad
• Treatments: Ivermectin

Criteria

Inclusion Criteria:

• COVID-19 patients at any stage of this disease

Exclusion Criteria:

• Patients of allergic history to Ivermectin or to doxycyline